Today, we invite you to focus on Interleukin-17 (IL-17), a promising therapeutic target for treating numerous inflammatory and autoimmune diseases. To support research in this area, we’ve curated a set of Chemspace Biologics designed to study the roles of this protein in various biological processes.
IL-17 is a versatile proinflammatory cytokine that plays vital roles in host defense, tissue repair, the pathogenesis of inflammatory and autoimmune disorders, and cancer progression. The therapeutic potential of targeting IL-17 has been validated through various breakthroughs, including FDA approval of monoclonal antibodies such as secukinumab (COSENTYX®) and ixekizumab (TALTZ™) for the treatment of moderate-to-severe plaque psoriasis.
Chemspace offers a comprehensive selection of Biologics, including antibodies, peptides, proteins, and RNAs, to enable detailed investigation of IL-17's involvement in normal and pathological biological pathways.
If you are interested in studying IL-17 or other promising therapeutic targets, or if you would like to utilize various biological services, please contact us at info@chem-space.com. We'll be glad to support your scientific journey.